OncoDx Panel

OncoDx Panel covers Colorectal Cancer (CRC) , Non-Small Cell Lung Cancer (NSCLC) and other solid tumor types. Our key capabilities include by detecting unique gene mutations in patients, assisting patients in selecting targeted drugs, and assisting in formulating and optimizing clinical trials treatment plan to achieve personalized diagnosis and treatment.

OncoDx Panel covers 198 oncogenes and MSI with direct therapeutic implications for 42 targeted drugs, including those recommended in the latest NCCN guidelines. The panel detects all classes of genomic alterations including SNV, CNV, InDels, and Fusion using routine FFPE samples, tumor tissue, biopsy, or DNA.

DETECTION SCOPE ——

What Detection Scope is Covered by OncoDx Panel?

SAMPLE TYPES ——

What Types of Samples Can Be Sent and Detected?

—— FEATURES ——

Clinical Applications and Other Features of OncoDx Panel
  • Clinical Application Scenarios
  • Technical Advantages
● Patients who are in need of drug guidelines with precision therapy for CRC, NSCLC or other solid tumors.
● Scientific research for oncologists.